Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties.
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination.
Protective effect of tanreqing injection on axon myelin damage in the brain of mouse model for experimental autoimmune encephalomyelitis.
Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans.
A review of the sheep-multiple sclerosis connection.
Transplantation of Human Adipose-Derived Stem Cells Enhances Remyelination in Lysolecithin-Induced Focal Demyelination of Rat Spinal Cord.
Multiple Sclerosis in Children.
Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis.
The gut microbiota and its correlations with the central nervous system disorders.
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death.
Coping Strategies in Multiple Sclerosis Patients with Frontal Cognitive Disorders.
Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
ER Chaperone BiP/GRP78 Is Required for Myelinating Cell Survival and Provides Protection during Experimental Autoimmune Encephalomyelitis.
Autophagic myelin destruction by schwann cells during wallerian degeneration and segmental demyelination.
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.
T Cell-Intrinsic Function of the Noncanonical NF-κB Pathway in the Regulation of GM-CSF Expression and Experimental Autoimmune Encephalomyelitis Pathogenesis.
Vitamin D status and ill health: a systematic review.
Heat shock protein 27 in multiple sclerosis relapses.
FDA approval of Isentress (raltegravir)
Ibuprofen-induced unilateral optic neuritis.
RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.
Pages
« first
‹ previous
…
170
171
172
173
174
175
176
177
178
…
next ›
last »